Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Divided on Sociedad Quimica Y Minera NYSE SQM Amid Market Shifts

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
TMUS stock news
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Analysts have been sharing their diverse opinions on Sociedad Quimica Y Minera (NYSE: SQM) over the last three months. The consensus rating for SQM stands at “Hold,” as determined by insights from 8 Wall Street analysts. Recent evaluations reveal a breakdown of 6 Buy Ratings, 4 Hold Ratings, and 2 Sell Ratings for SQM, with an average price target of $59.64 during this time period.

Market conditions and company performance have prompted analysts to make adjustments to their ratings and price targets. For instance, Joel Jackson from BMO Capital revised the rating to Outperform, setting a new price target of $70.00. Meanwhile, Corinne Blanchard from Deutsche Bank shifted the rating to Hold with a price target of $48.00. Overall, there has been an 8.33% decrease in the average price target for SQM, indicating a shift towards a more negative sentiment among analysts.

As of March 1, 2024, these changes reflect the evolving landscape surrounding SQM and its potential trajectory in the market.

SQM Stock Price Jumps 3.52% on March 1, 2024: Investors Should Monitor Performance

On March 1, 2024, SQM stock experienced a positive trading day as it saw a 3.52% increase in its share price. The stock opened at $50.94, which was $1.22 higher than its previous close. Throughout the trading day, the price of SQM shares continued to rise, ultimately closing at $52.69, a $1.75 increase from the previous day.

Investors should take note of the recent price increase and monitor SQM’s performance in the coming days to see if this positive trend continues. It will be important to watch for any potential catalysts or news that could impact the stock’s movement.

SQM Stock Declines in Total Revenue and Net Income: Impact on Investors on March 1, 2024

On March 1, 2024, SQM (Sociedad Química y Minera de Chile) stock experienced a decline in its total revenue and net income compared to the previous year and the last quarter. According to data from CNN Money, the total revenue for SQM was $7.47 billion over the past year, which represents a 30.28% decrease from the previous year. In the fourth quarter of the same year, the total revenue further decreased to $1.31 billion, marking a 28.73% decrease from the previous quarter.

Similarly, the net income for SQM was $2.01 billion over the past year, reflecting a 48.48% decrease from the previous year. In the fourth quarter, the net income dropped to $203.20 million, showing a significant 57.61% decrease from the previous quarter.

These declines in total revenue and net income could have had a negative impact on SQM’s stock performance on March 1, 2024. Investors may have reacted to the lower financial results by selling off their shares, leading to a decrease in the stock price.

It is important to note that the earnings per share (EPS) for SQM is currently unavailable, as there is not enough data to create an insight. EPS is a key financial metric that indicates a company’s profitability and is often used by investors to evaluate a stock’s performance.

Overall, the decrease in total revenue and net income for SQM may have contributed to a decline in the stock price on March 1, 2024. Investors should continue to monitor the company’s financial performance and any updates on earnings per share to make informed decisions about their investments in SQM.

Tags: SQM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
financial-data

Expert Opinions on Micron Technology A Diverse Outlook

Market-stocks

Hess CEOs Insider Sale and Company Performance Analysis

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Bearish Options Activity Indicates Investor Sentiment for JDcom

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com